Filing Details
- Accession Number:
- 0000899243-22-012476
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-28 16:31:12
- Reporting Period:
- 2022-03-24
- Accepted Time:
- 2022-03-28 16:31:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783328 | Tscan Therapeutics Inc. | TCRX | Biological Products, (No Disgnostic Substances) (2836) | 825282075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1860597 | M. Brian Silver | C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2022-03-24 | 15,000 | $3.40 | 26,885 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.375 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
